分享产品介绍 评论(0)
物种
Human分子别名
LIR5,HM18Accession
AAH26309表达序列
Gln22-Glu259, with C-terminal Human IgG1 Fc表达宿主
HEK293分子量
60-70kDa
纯度
＞95% by SDS-PAGE内毒素含量
<0.1EU/μg标记
Unconjugated标签
Human Fc性状
Lyophilized Powder缓冲体系
PBS, pH7.4溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.文献引用
1. CHIEN, KELLY S., CLASS, CALEB A., MONTALBAN-BRAVO, GUILLERMO, et al. LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents [J].Leukemia and lymphoma,2020,61(5/6):1493-1499.
Leukocyte immunoglobulin (Ig)-like receptor B4 (LILRB4) is a member of leukocyte Ig-like receptors (LILRs). LILRB4 is encoded in the leukocyte receptor cluster, which is on human chromosome 19q13.4. The structure and function of LILRs are similar to those of other leukocyte receptor cluster receptors, such as killer cell immunoglobulin-like receptors. Leukocyte immunoglobulin-like receptor (LILRB4) is a kind of inhibitory receptor that plays a key role in immune checkpoint pathways. Inhibitory receptors also participate in achieving balance between activating and inhibitory actions to ensure immune responses to pathogens in the immune system. However, they not only protect the host from autoimmune responses, but also preserve peripheral tolerance. LILRB4 also regulates immune responses, and its role in regulating immune responses is mostly controlled by its ligands.
电泳
1ug (R: reducing conditions, N: non-reducing conditions).
ELISA
Immobilized LILRB4/CD85k/ILT3 Fc Chimera Protein, Human (Cat. No. UA010561) at 2.0μg/mL (100μL/well) can bind LILRB4/CD85k/ILT3 Recombinant Rabbit mAb (S-280-51) (Cat. No. S0B0349) with EC50 of 0.90-1.29ng/mL.
评论(0)